84 results
8-K
EX-99.1
URGN
UroGen Pharma Ltd.
13 Aug 24
UroGen Pharma Ahead of Schedule to Complete UGN-102 NDA Submission and Reports 2024 Second Quarter Financial Results and Business Highlights
8:01am
presentations at the AUA 2024 Annual Meeting. Independent long-term, real-world analyses explored use of the product in broad patient types, and with different … in 2023.
Interest Expense on Long-Term Debt: Interest expense related to the up to $200 million term loan facility with funds managed by Pharmakon
8-K
EX-10.1
URGN
UroGen Pharma Ltd.
8 Aug 24
Departure of Directors or Certain Officers
4:30pm
: (a) to promote the Company’s mission, long term goals and targets; (b) to create appropriate incentives for the Company’s directors and officers with the aim … , based on their contribution and their efforts to the development of the Company’s business and promotion of its goals, in the short and long term.
1.5
8-K
EX-1.1
URGN
UroGen Pharma Ltd.
18 Jun 24
UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants
5:07pm
; and (iii) there has not been any material decrease in the share capital or any material increase in any short-term or long-term indebtedness
424B5
7hspl sks
18 Jun 24
Prospectus supplement for primary offering
5:05pm
424B5
d7exweihlkyx hf72
17 Jun 24
Prospectus supplement for primary offering
4:19pm
8-K
EX-99.1
w70zy6u5h8iz5 x7k
13 May 24
ENVISION data expected to support completion of UGN-102 NDA in Q3 2024
8:01am
8-K
EX-99.1
2ywgit7urpi
14 Mar 24
UroGen Pharma Delivers Double Digit JELMYTO® Growth and Prepares for the Next Phase of the Company with on Track Rolling Submission of UGN-102
8:16am
8-K
EX-99.1
garb9u7dw pfx5mm
4 Mar 24
Regulation FD Disclosure
7:00am
8-K
EX-99.1
igml7w87kagjhxjp36a
7 Feb 24
Regulation FD Disclosure
4:15pm
8-K
EX-99.1
r41t7nh49rmtbsxe9qc
14 Nov 23
UroGen Pharma Reports Third Quarter 2023 Financial Results
12:00am
8-K
EX-99.1
qyflndr
10 Aug 23
UroGen Pharma Reports Record JELMYTO Quarterly Sales and Recent Corporate Developments
8:01am